VISIODORON EUPHRASIA gtt opht MD 20 x 0.4 ml

7680495370036 CH-49537 20.02.
VISIODORON EUPHRASIA gtt opht MD 20 x 0.4 ml
VISIODORON EUPHRASIA gtt opht MD 20 x 0.4 ml
VISIODORON EUPHRASIA gtt opht MD 20 x 0.4 ml
1 / 3
google

Details

Product number
4953702
CPT
-
Packaging group
20 x 0.4
Unit
ml
Composition
euphrasia officinalis D3 397.34 mg, dilutio, excipiens ad solutionem pro 0.4 ml.

Articles (1)

Visiodoron Euphrasia Monodosen, Augentropfen (Monodosen)
Augentropfen (Monodosen)
20 x 0.4
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/09/2022
Patient information leaflet
Français
02/09/2022
Patient information leaflet
Italien
02/09/2022

Detailed composition

Substance Quantity Type Category
(N/A)
397.34 MG Substance Wirkstoff (Principe actif)
natrii citras dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Weleda AG

4144 Arlesheim

Authorization information

Swissmedic authorization number
49537
Drug name
Visiodoron Euphrasia, Augentropfen
Galenic form
AUGT
Authorization status
Z
Dispensation category
D
First authorization
11/09/1989
Authorization expiration date
31/12/9999
IT number
20.02.
Domain
Human medicine
Field of application
Gemäss der anthroposophischen Menschen- und Naturerkenntnis bei Reizzuständen der Augenbindehaut wie geröteten, tränenden und müden Augen, bei Schwellungen des Lides sowie bei Fremdkörper- und Austrocknungsgefühl

Packaging details

Description (FR)
VISIODORON EUPHRASIA, collyre MD 20 x 0.4ml
Description (DE)
VISIODORON EUPHRASIA, Augentropfen MD 20 x 0.4ml
Market launch
11/09/2008
Narcotic (BTM)
No

Other packaging sizes

VISIODORON EUPHRASIA, collyre fl 10 ml
10 ML
GTIN: 7680495370029
View